10-Q

Use these links to rapidly review the document
Table of Contents

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

FORM 10-Q

ý	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended September 30, 2007
or
o	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from            to
Commission File No. 000-51754

Crocs, Inc.
(Exact name of registrant as specified in its charter)

Delaware	20-2164234
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

6328 Monarch Park Place, Niwot Colorado 80503
(Address of Registrant's principal executive offices)

(303) 848-7000
(Registrant's telephone number, including area code)

        Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ý    No o

        Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, or a non-accelerated filer. See definition of "accelerated filer and large accelerated filer" in Rule 12b-2 of the Exchange Act. (Check one):

Large accelerated filer o Accelerated filer o Non-accelerated filer ý

        Indicate by check mark whether the registrant is shell company (as defined in Rule 12b-2 of the Exchange Act). Yes o    No ý

        As of October 31, 2007, Crocs, Inc. had 82,459,122 shares of its $0.001 par value common stock outstanding.

Crocs Inc.

Form 10-Q

Quarter Ended September 30, 2007

Table of Contents

2

PART I FINANCIAL INFORMATION

ITEM 1.    Financial Statements

CROCS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(In thousands, except share and per share data)

(Unaudited)

		Three Months Ended September 30,						Nine Months Ended September 30,
		2007			2006			2007			2006
Revenues		$	256,275		$	111,345		$	622,554		$	241,824
Cost of sales			100,883			46,521			250,729			106,348
Gross profit			155,392			64,824			371,825			135,476
Selling, general and administrative expense			77,156			33,344			187,958			70,345
Income from operations			78,236			31,480			183,867			65,131
Interest expense			191			162			306			533
Other income—net			(1,158	)		(657	)		(2,074	)		(1,310	)
Income before income taxes			79,203			31,975			185,635			65,908
Income tax expense			22,655			10,449			55,690			22,275
Net income		$	56,548		$	21,526		$	129,945		$	43,633
Dividends on redeemable convertible preferred shares			—			—			—			33
Income attributable to common stockholders		$	56,548		$	21,526		$	129,945		$	43,600
Income per common share: (note 4)
	Basic	$	0.69		$	0.28		$	1.62		$	0.60
	Diluted	$	0.66		$	0.27		$	1.55		$	0.55
Weighted average common shares:
	Basic		81,543,769			77,546,724			80,362,112			73,350,638
	Diluted		85,370,351			80,931,446			83,842,675			79,453,690

See notes to condensed consolidated financial statements.

3

CROCS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED BALANCE SHEETS

(In thousands, except share data)

(Unaudited)

			As of
			September 30, 2007			December 31, 2006
ASSETS
Current assets:
	Cash and cash equivalents		$	55,659		$	42,656
	Restricted cash			4,220			2,890
	Short-term investments			16,700			22,325
	Accounts receivable, net			160,642			65,588
	Inventories			195,256			86,210
	Deferred tax assets			3,709			3,690
	Prepaid income tax			—			4,715
	Prepaid expenses and other current assets			21,970			9,617
		Total current assets		458,156			237,691
Property and equipment, net				72,186			34,849
Goodwill				23,645			11,552
Intangible assets, net				26,969			12,210
Deferred tax assets, net				2,940			1,280
Other assets				10,566			1,875
		Total assets	$	594,462		$	299,457
LIABILITIES AND STOCKHOLDERS' EQUITY
Current liabilities:
	Accounts payable		$	80,955		$	43,794
	Accrued expenses and other current liabilities			85,148			31,109
	Income taxes payable			2,787			12,465
	Current portion of long-term debt and capital lease obligations			194			541
		Total current liabilities		169,084			87,909
Long-term debt and capital lease obligations, net of current portion				21			116
Deferred tax liabilities				3,487			1,688
Other liabilities				9,271			1,486
		Total liabilities		181,863			91,199
Commitments and contingencies (note 8, 12 and 13)
Stockholders' equity:
	Common shares, par value $0.001 per share; 250,000,000 shares authorized, 82,003,587 and 78,681,418 shares issued and outstanding as of September 30, 2007 and 2006			82			77
	Preferred shares, par value $0.001 per share; 5,000,000 shares authorized, no shares issued and outstanding as of September 30, 2007 and 2006			—			—
	Additional paid-in capital			197,775			131,796
	Deferred compensation			(3,052	)		(5,702	)
	Retained earnings			211,027			81,081
	Accumulated other comprehensive income			6,767			1,006
		Total stockholders' equity		412,599			208,258
		Total liabilities and stockholders' equity	$	594,462		$	299,457

See notes to condensed consolidated financial statements.

4

CROCS, INC. AND SUBSIDIARIES

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In thousands)

(Unaudited)

				For the Nine Months Ended September 30,
				2007			2006
Cash flows from operating activities:
	Net income			$	129,945		$	43,633
	Adjustments to reconcile net income to net cash provided by (used in) operating activities:
		Depreciation and amortization			13,608			5,238
		Loss on disposal of fixed assets			225			330
		Unrealized foreign exchange gains			(5,484	)		—
		Deferred income taxes			(128	)		(113	)
		Share-based compensation			16,041			7,195
		Excess tax benefit on share-based compensation			(38,602	)		(5,047	)
		Bad debt expense			1,395			1,389
		Changes in operating assets and liabilities, net of effect of acquired businesses:
			Accounts receivable		(92,134	)		(43,741	)
			Inventories		(101,667	)		(20,415	)
			Prepaid expenses and other assets		(14,931	)		(8,397	)
			Accounts payable		30,347			7,974
			Accrued expenses and other liabilities		83,590			15,364
			Cash provided by operating activities		22,205			3,410
Cash flows from investing activities:
	Purchases of short-term investments				(66,780	)		(31,800	)
	Sales of short-term investments				72,405			6,400
	Cash paid for purchases of property and equipment				(41,605	)		(13,042	)
	Cash paid for intangible assets				(14,160	)		(1,688	)
	Proceeds from the disposal of property and equipment				—			340
	Acquisition of businesses, net of cash acquired				(11,280	)		—
	Restricted cash				(1,083	)		—
			Cash used in investing activities		(62,503	)		(39,790	)
Cash flows from financing activities:
	Proceeds from note payable, net				—			1,811
	Repayment of long-term debt and capital lease obligations				(621	)		(12,222	)
	Proceeds from initial public offering, net of offering costs				—			94,454
	Excess tax benefit on share-based compensation				38,602			5,047
	Exercise of stock options				13,992			564
	Payment of preferred dividends				—			(171	)
			Cash provided by financing activities		51,973			89,483
Effect of exchange rate changes on cash					1,328			(10	)
Net increase in cash and cash equivalents					13,003			53,093
Cash and cash equivalents—beginning of period					42,656			4,787
Cash and cash equivalents—end of period				$	55,659		$	57,880
Supplemental disclosure of cash flow information—cash paid during the period for:
Interest				$	175		$	296
Income taxes				$	12,760		$	19,583
Supplemental disclosure of non-cash, investing, and financing activities:
In conjunction with the acquisitions made liabilities were assumed as follows:
		Fair value of assets acquired		$	7,074			—
		Cash paid for capital stock			5,093			—
			Liabilities assumed	$	1,981			—
	Assets acquired under capitalized leases			$	—		$	563
	Accrued purchases of property and equipment			$	4,730			—
	Accrued Jibbitz and Bite purchase price			$	5,011			—

See notes to condensed consolidated financial statements.

5

CROCS, INC. AND SUBSIDIARIES

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

(Unaudited)

1. CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

        The accompanying condensed consolidated financial statements of Crocs, Inc. and subsidiaries (collectively, "Crocs" or the "Company") have been prepared in accordance with accounting principles generally accepted in the United States for interim financial information and with the rules and regulations for reporting on Form 10-Q. Accordingly, they do not include certain information and disclosures required for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation have been included and are of a normal recurring nature. Operating results for the three and nine months ended September 30, 2007 are not necessarily indicative of the results that may be expected for the fiscal year ending December 31, 2007.

        These statements should be read in conjunction with the consolidated financial statements and footnotes included in the Company's Form 10-K for the year ended December 31, 2006. Except for derivatives and hedging activities, which are described below, the accounting policies used in preparing these condensed consolidated financial statements are the same as those described in Note 2 to the consolidated financial statements in the Company's Form 10-K.

Accounting for Derivatives and Hedging Activities

        The Company uses derivative financial instruments to limit exposure to changes in foreign currency exchange rates. The Company accounts for derivatives pursuant to the Financial Accounting Standards Board ("FASB") issued Statement of Financial Accounting Standards ("SFAS") SFAS No. 133, "Accounting for Derivative Instruments and Hedging Activities" ("FAS 133"), as amended and interpreted. FAS 133 establishes accounting and reporting standards for derivative instruments and requires that all derivatives be recorded at fair value on the balance sheet. Changes in the fair value of derivative financial instruments are recognized in net income.

Stock Split

        On May 2, 2007, the Board of Directors of the Company declared a two-for-one stock split of the Company's common shares, which was effected in the form of a 100% common stock dividend distributed on June 14, 2007. All references to share and per share amounts in the consolidated financial statements and accompanying notes to the consolidated financial statements have been retroactively restated to reflect the two-for-one stock split.

Income Taxes

        In July 2006, the FASB issued Interpretation No. 48, Accounting for Uncertainty in Income Taxes ("FIN 48"). FIN 48 requires the use of a two-step approach for recognizing and measuring tax benefits taken or expected to be taken in a tax return and disclosures regarding uncertainties in income tax positions. FIN 48 is effective for fiscal years beginning after December 15, 2006. Only tax positions that meet the more likely than not recognition threshold at the effective date may be recognized on adoption of FIN 48. The adoption of FIN 48 did not have a material impact on the Company's condensed consolidated balance sheet, statement of operations or cash flows. The Company had unrecognized tax benefits of $614,000 at January 1, 2007 and $3.0 million as of September 30, 2007. The Company expects that the requirements of FIN 48 may add volatility to its effective tax rate and, therefore, the expected income tax expense in future periods.

6

        The Company's unrecognized benefits consist primarily of tax positions related to intercompany transfer pricing in multiple jurisdictions. The Company is currently negotiating with tax authorities to obtain rulings regarding its transfer pricing policies. Conclusion of these negotiations could result in a significant increase or decrease in the amount of unrecognized tax benefits during the next twelve months. The Company is currently unable to estimate the range of the possible change.

        Interest and penalties related to income tax liabilities are included in income tax expense. The balance of accrued interest and penalties recorded in the consolidated statement of operations at January 1, 2007 was $128,000 related to the adoption of FIN 48 and an additional $323,000 accrued during the nine months ended September 30, 2007 for a total of $451,000.

        The Company is potentially subject to U.S. federal, state and local or non-U.S. income tax audits by taxing authorities for years 2005 and 2006. In addition, the Company's Canadian subsidiary, Foam Creations, is potentially subject to Federal and Provincial income tax audits for years 2002 through 2006.

2. RECENT ACCOUNTING PRONOUCEMENTS

        In September 2006, the FASB issued SFAS No. 157, Fair Value Measurement ("SFAS 157"), which defines fair value, establishes a framework for measuring fair value, and expands disclosures about fair value measurements. SFAS 157 is effective for financial statements issued for the first annual or interim reporting period beginning after November 15, 2007. The Company will adopt SFAS 157 effective January 1, 2008. The Company is currently evaluating the impact this new standard will have on its future results of operations and financial position.

        In February 2007, the FASB issued SFAS No. 159, The Fair Value Option for Financial Assets and Financial Liabilities ("SFAS 159"). SFAS 159 permits entities to choose to measure many financial instruments and certain other items at fair value. SFAS 159 will be effective at the beginning of fiscal 2008. The Company is currently evaluating the impact this new standard will have on its future results of operations and financial position.

3. STOCK-BASED COMPENSATION

        During the three months ended September 30, 2007, the Company issued 499,900 options to purchase shares of its common stock to eligible employees and non-employee directors with a weighted average grant date fair value of $20.65 and a weighted average exercise price of $54.00. During the three months ended June 30, 2007, the Company issued 392,200 options to purchase shares of its common stock to eligible employees with a weighted average grant date fair value of $18.93 and a weighted average exercise price of $38.36. During the three months ended March 31, 2007, the Company issued in January and February 2007, 1,030,000 and 20,000 options, adjusted for the stock split that occurred on June 14, 2007, to purchase shares of its common stock to executive officers, with grant date fair values of $11.22 and $11.90 per share, respectively, and exercise prices of $22.92 and $24.36 per share, respectively as adjusted. The Company also granted in the three months ended March 31, 2007 an aggregate of 807,100 options, split adjusted, to purchase shares of its common stock to eligible employees with grant date fair values of $11.78 and $11.90 and exercise prices of $23.93 and $24.36 per share. All options granted to employees will vest ratably over four years with the first year

7

on a "cliff" basis and monthly vesting for the remaining three years. Options granted to non-employee directors will vest in four equal annual installments on the date of the annual meeting of stockholders each year. Compensation expense is recognized equally over the four year vesting period.

        Stock-based compensation, including options and non-vested shares, was $6.3 million and $16.0 million in the three and nine months ended September 30, 2007, respectively, and $2.8 million and $7.2 million in the three and nine months ended September 30, 2006, respectively. For the three and nine months ended September 30, 2007, $658,000 and $2.5 million, respectively, of the stock-based compensation was capitalized in inventory as part of the overhead allocation and intangible assets in the condensed consolidated balance sheet. During the three and nine months ended September 30, 2007, 775,095 and 2,821,519 options to purchase common stock were exercised, 39,210 and 405,589 options to purchase common stock were forfeited, and 208,626 and 490,926 shares of restricted stock vested, respectively.

4. EARNINGS PER SHARE

        Basic earnings per common share ("EPS") is computed by dividing the net income available to common stockholders by the weighted average number of common shares outstanding for the period. Diluted EPS reflects the potential dilution from securities that could share in the earnings of the Company. Antidilutive securities are excluded from diluted EPS (in thousands except share and per share data).

		Three Months Ended September 30,				Nine Months Ended September 30,
		2007		2006		2007		2006
Reconciliation of net income for dilutive computation:
	Income attributable to common stockholders	$	56,548	$	21,526	$	129,945	$	43,600
	Preferred dividend		—		—		—		33
	Net income for dilutive computation	$	56,548	$	21,526	$	129,945	$	43,633
Basic income per common share:
	Weighted average common shares outstanding		81,543,769		77,546,724		80,362,112		73,350,638
	Basic income per common share	$	0.69	$	0.28	$	1.62	$	0.60
Diluted income per common share:
	Weighted average common shares outstanding		81,543,769		77,546,724		80,362,112		73,350,638
	Dilutive effect of preferred stock		—		—		—		2,129,370
	Dilutive effect of stock options		3,587,728		2,562,192		3,109,047		2,884,486
	Dilutive effect of unvested stock		238,854		822,530		371,516		1,089,196
	Weighted average diluted common shares outstanding		85,370,351		80,931,446		83,842,675		79,453,690
	Diluted income per common share	$	0.66	$	0.27	$	1.55	$	0.55

8

        For the three and nine months ended September 30, 2007 and 2006 there were options outstanding to purchase 647,100 and 4.0 million shares of the Company's common stock with a weighted-average exercise price per share of $50.44 and $12.07, respectively, which could potentially dilute basic earnings per share in the future, but which were not included in diluted earnings per share as their effect was antidilutive.

5. SHORT-TERM INVESTMENTS

        At September 30, 2007, the Company's short-term investments consisted exclusively of auction rate securities. Auction rate securities are variable rate bonds of states and joint municipal agencies tied to short-term interest rates with maturities on the face of the underlying securities in excess of 90 days. These securities have interest rate resets through a modified Dutch auction, at pre-determined short-term intervals, usually every 7, 28 or 35 days. They trade at par and are callable at par on any interest payment date at the option of the issuer. Interest paid during a given period is based on the interest rate determined during the prior auction. The Company recorded such securities as short-term investments based on the short-term nature and structure, the frequency with which the interest rate resets and the ability to sell auction rate securities at par and at the Company's discretion with the intent of meeting the Company's short-term working capital requirements.

        Investments in auction rate securities are classified as available-for-sale and are reported at fair value in the Company's consolidated balance sheets. There were no unrealized gains or losses as of September 30, 2007. The following table summarizes the contractual maturities of available-for-sale securities at September 30, 2007 and December 31, 2006 (in thousands).

	September 30, 2007		December 31, 2006
Within one year	$	—	$	—
After one year through five years		—		—
After five years through ten years		900		—
After ten years		15,800		22,325
	$	16,700	$	22,325

        Proceeds from sales of short-term investments totaled $45.4 million and $72.4 million in the three and nine months ended September 30, 2007, respectively. Purchases of short-term investments totaled $37.7 million and $66.8 million in the three and nine months ended September 30, 2007, respectively. There were no realized gains or losses related to the sales of short-term investments in the three and nine months ended September 30, 2007.

9

6. INVENTORIES

        Inventories by major classification are as follows (in thousands):

	September 30, 2007		December 31, 2006
Finished goods	$	170,460	$	78,938
Work-in-progress		2,498		445
Raw materials		22,298		6,827
	$	195,256	$	86,210

7. GOODWILL AND INTANGIBLE ASSETS

        The following table summarizes the Company's identifiable intangible assets as of September 30, 2007 and December 31, 2006 (in thousands):

			September 30, 2007						December 31, 2006
			Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount		Gross Carrying Amount		Accumulated Amortization		Net Carrying Amount
Finite lived intangible assets:
	Patents, copyrights, and trademarks		$	2,929	$	78	$	2,851	$	1,441	$	12	$	1,429
	Customer relationships			5,341		1,964		3,377		3,547		657		2,890
	Core technology			4,828		3,142		1,686		4,154		2,082		2,072
	Non-competition agreement			636		307		329		636		212		424
	Software developed for internal use			19,704		1,131		18,573		5,516		274		5,242
		Total finite lived intangible assets	$	33,438	$	6,622	$	26,816	$	15,294	$	3,237	$	12,057
Indefinite lived intangible assets:
	Jibbitz trade name		$	153	$	—	$	153	$	153	$	—	$	153
		Total intangible assets	$	33,591	$	6,622	$	26,969	$	15,447	$	3,237	$	12,210

        On July 27, 2007, the Company acquired all of the assets of Bite, LLC ("Bite") for $1.75 million in cash and the assumption of $1.3 million in debt, plus a potential earn out of up to $1.75 million based on Bite achieving certain earnings targets over a three year period. Bite is a designer and manufacturer of comfortable and supportive performance shoes and sports sandals sold worldwide in five categories including, golf, adventure, healthy lifestyle, travel and watersports. The Company recorded $512,000 in customer relationships and $530,000 in goodwill on the date of acquisition for Bite. The Company is finalizing its purchase accounting in the fourth quarter and management believes any adjustment will not be material.

        On January 31, 2007, the Company acquired substantially all of the assets of Ocean Minded, LLC ("Ocean Minded") for $1.75 million in cash, plus a potential earn-out of up to $3.75 million based on Ocean Minded achieving certain earnings targets over a three year period. Ocean Minded is a designer and manufacturer of high quality leather and EVA (Ethylene Vinyl Acetate) based sandals primarily for the beach, adventure and action sports markets. The Company recorded $600,000 in customer

10

relationships and intangible assets and $953,000 in goodwill on the date of acquisition for Ocean Minded.

        On June 26, 2007, the Company amended the membership interest purchase agreement with Jibbitz, LLC ("Jibbitz") (Purchase Agreement) to amend the terms of the potential earn-out consideration included in the Purchase Agreement. The amendment removed the earnings targets for payment of the earn-out with $3.5 million payable on the effective date of the amended Purchase Agreement and the remaining $6.5 million payable in equal monthly installments of $500,000 due on the first business day for the following thirteen months. The Company recorded the additional $9.77 million purchase price to goodwill in the second quarter of 2007.

        The Company's goodwill balance of $23.6 million and $11.6 million as of September 30, 2007 and December 31, 2006, respectively, relates predominately to the acquisitions of Bite and Ocean Minded in 2007, Jibbitz, Fury and EXO in 2006 as well as the acquisition of Foam Creations in 2004.

8. COMMITMENTS AND CONTINGENCIES

        On July 26, 2005, the Company entered into an amended and restated four year Supply Agreement with Finproject S.P.A., the former majority owner of Foam Creations, where the Company has the exclusive right to purchase the material for the manufacture of finished shoe products, except for certain current customer dealings (including boot manufacturers). Based on the supply agreement, the Company has contractual purchase requirements to maintain exclusivity throughout the agreement. The pricing is to be agreed on each quarter and fluctuates based on order volume, currency fluctuations and raw material prices.

        The Company indemnifies certain of its vendors and its directors and executive officers for specified claims. To date, the Company has not paid or been required to defend any indemnification claims, and accordingly, has not accrued any amounts for its indemnification obligations.

9. MATERIAL CONTRACTS

Deferred Compensation Plan

        On May 2, 2007, the Board of Directors of the Company approved the 2007 Executive Deferred Compensation Plan ("the Plan") for certain highly compensated employees. On July 9, 2007 the Company's stockholders approved the Plan at the annual stockholders' meeting. The Plan, which is unfunded, allows for the Company or the employee to defer all or a portion of his or her compensation and requires any performance bonus under the 2007 Bonus Plan in excess of two times the minimum performance bonus percentage amount to be automatically deferred under the Plan terms, with a maximum deferral amount of $6.0 million. Under the terms of the Plan, all required deferrals will vest ratably on a quarterly basis from March 31, 2008 through December 31, 2010.

Hedging Transactions and Derivative Financial Instruments

        The Company is exposed to global market risks, including the effect of changes in foreign currency exchange rates. The Company uses derivatives to manage financial exposures that occur in the normal course of business. The Company does not hold or issue derivatives for trading purposes.

11

        The Company formally documents all relationships between hedging instruments and hedged items, as well as its risk-management objective and strategy for undertaking hedge transactions. This process includes linking all derivatives to either specific assets and liabilities on the balance sheet, specific firm commitments or forecasted transactions. The Company has entered into forward exchange contracts to hedge certain portions of future cash flows denominated in foreign currencies. None of the derivative instruments entered into prior to September 30, 2007, whether settled before September 30, 2007 or unsettled at September 30, 2007, have been designated as hedges and, as such, hedge accounting has not been applied.

10. OPERATING SEGMENTS AND RELATED INFORMATION

        The Company operates in the consumer products industry in which the Company designs, manufactures, markets and distributes footwear, apparel and accessories. Operating results are assessed on an aggregate basis to make decisions about necessary resources and in assessing performance. Consequently, under the provisions of SFAS No. 131, Disclosure About Segments of an Enterprise and Related Information ("SFAS 131"), and based on the nature of the financial information that is received by the chief executive officer as chief operating decision maker, the Company has one reportable segment for financial statement purposes.

        The Company's sales by product line are as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2007		2006		2007		2006
Shoes	$	228,445	$	109,950	$	557,067	$	236,162
Other		27,830		1,395		65,487		5,662
	$	256,275	$	111,345	$	622,554	$	241,824

12

        Geographic information about the United States and international territories is presented below, the Company has allocated revenues to the geographical locations based on the location of the customer (in thousands):

		Three Months Ended September 30,				Nine Months Ended September 30,
		2007		2006		2007		2006
Revenue
United States		$	125,403	$	70,476	$	323,768	$	163,462
Canada			10,116		11,929		36,293		24,490
Mexico			1,242		630		5,533		959
	North America total		136,761		83,035		365,594		188,911
Asia			53,902		15,840		110,356		33,097
Europe			58,083		11,795		134,437		19,373
Other			7,529		675		12,167		443
		$	256,275	$	111,345	$	622,554	$	241,824
Total for countries outside the United States		$	130,872	$	40,869	$	298,786		78,362

		September 30, 2007		December 31, 2006
Long-lived assets
United States		$	37,068	$	19,482
Canada			13,829		9,161
Mexico			2,493		1,204
	North America total		53,390		29,847
Asia			6,100		2,821
Europe			9,419		2,181
Other			3,277		—
		$	72,186	$	34,849
Total for countries outside the United States		$	35,118	$	15,367

        There were no customers that comprised greater than 10% of the consolidated revenues of the Company for the three and nine months ended September 30, 2007 and 2006.

13

11. COMPREHENSIVE INCOME

        Comprehensive income for the three and nine months ended September 30, 2007 and 2006 was as follows (in thousands):

	Three Months Ended September 30,				Nine Months Ended September 30,
	2007		2006		2007		2006
Net income	$	56,548	$	21,526	$	129,945	$	43,633
Foreign currency translation		4,177		143		5,761		369
Comprehensive income	$	60,725	$	21,669	$	135,706	$	44,002

12. LEGAL PROCEEDINGS

        In January 2005, Crocs's direct subsidiary Foam Creations filed a lawsuit against Holey Soles Holdings Ltd. ("Holey Soles") in the Federal Court of Canada, Trial Division in Toronto, Ontario. In early 2007 Crocs was added as a co-plaintiff to the action. The complaint alleges trademark and copyright infringement relating to the design of some of its shoe models. Crocs is seeking a permanent injunction with respect to any further acts of infringement of its intellectual property, as well as damages and attorneys' fees. The first round of examinations for discovery are now completed. Holey Soles recently filed a motion for summary judgement scheduled to be heard on January 31, 2008. The action is still pending.

        In August 2005, Holey Soles filed a lawsuit against Crocs in the United States District Court for the Southern District of New York. Holey Soles seeks a declaratory judgment that Crocs does not have any valid copyright or trade dress rights with respect to the design of its footwear. In addition, Holey Soles seeks a declaratory judgment that the manufacture, sale and distribution of its footwear products does not constitute unfair competition and does not infringe on Crocs' copyrights or trade dress rights. On Crocs' motion, the action has been transferred to the United States District of Colorado where it has been stayed pending the outcome of the International Trade Commission ("ITC") Investigation No. 337-TA-567 discussed below. The Company does not expect the ultimate resolution of this matter will have a material adverse impact on its business.

        On March 31, 2006, Crocs filed a complaint with the ITC against Acme Ex-Im, Inc., Australia Unlimited, Inc., Cheng's Enterprises, Inc., Collective Licensing International, LLC, D. Myers & Sons, Inc., Double Diamond Distribution, Ltd., Effervescent, Inc., Gen-X Sports, Inc., Holey Soles Holdings, Ltd., Inter-Pacific Trading Corporation, and Shaka Holdings, Inc., alleging patent and trade dress infringement and seeking an exclusion order banning the importation and sale of infringing products. The utility and design patents asserted in the complaint were issued to Crocs, Inc. on February 7, 2006 and March 28, 2006 respectively, by the United States Patent and Trademark Office. The ITC has issued final determinations terminating Shaka Holdings, Inc., Inter-Pacific Trading Corporation, Acme Ex-Im, Inc., D. Myers & Sons, and Australia Unlimited, Inc. from the ITC investigation No. 337-TA-567 on the basis of settlement and Cheng's Enterprises, Inc. on the suspension of accused activities. The ITC Administrative Law Judge ("ALJ") issued an Initial Determination of non-infringement related to one of the patents at issue. Crocs filed a petition with the Commission to review this determination. The Commission granted Crocs's petition and on February 15, 2007, after briefing by the parties, the Commission vacated the ALJ's determination of non-infringement with

14

respect to the remaining respondents and remanded it to the ALJ for further proceedings consistent with the Commission's order. In light of the Commission's Order, the procedural schedule and hearing date were reset pursuant to Order No. 38. A trial was held before the ALJ from September 4th to 17th, 2007. After post-trial briefing was completed, the ALJ has set a target date of April 11, 2008 for completion of the Investigation. The Company does not expect the ultimate resolution of this matter to have a material adverse impact on its business.

        On April 3, 2006, Crocs filed a complaint in the U.S. District Court for the District of Colorado alleging patent and trade dress infringement and seeking injunctive relief against Acme EX-IM, Inc., Australia Unlimited, Inc., Cheng's Enterprises, Inc., Collective Licensing International, LLC, D. Myers & Sons, Inc., Double Diamond Distribution, Ltd., Effervescent, Inc., Gen-X Sports, Inc., Holey Soles Holdings, Ltd., Inter-Pacific Trading Corporation, Shaka Holdings, Inc., and Does 1-10. The utility and design patents asserted in the complaint were issued to Crocs, Inc. on February 7, 2006 and March 28, 2006 respectively, by the United States Patent and Trademark Office. Consent judgments have been entered against Shaka Holdings, Inc., Interpacific Trading Corporation and Acme Ex-Im, Inc. Crocs has entered into a settlement agreements with Australia Unlimited, Inc., and on January 25, 2007 filed a stipulation for dismissal of all claims and counterclaims. Crocs has entered into a settlement agreement with D. Myers & Sons, Inc. and on May 23, 2007 the U.S. District Court entered a consent judgment against D. Myers & Sons, Inc. The Company does not expect the ultimate resolution of this matter will have a material adverse impact on its business.

        On January 29, 2007, Crocs filed an action in Colorado District Court, Boulder County, alleging breach of contract by Australia Unlimited. Crocs alleges Australia Unlimited breached the settlement agreement from the prior litigation by introducing a new shoe design not approved by Crocs. Crocs obtained a temporary restraining order enjoining Australia Unlimited sale of the new shoe; however, Crocs' motion for preliminary injunction was denied. Australia Unlimited removed the case to federal court, Case No. 07CV00221, and alleged a counterclaim for breach of contract and that it is entitled to recover damages for the time that the temporary restraining order was in effect. On November 6, 2007, based on information learned in discovery, Crocs filed an amended complaint against Australia Unlimited alleging claims for patent infringement, trade dress infringement and unfair competition. Crocs seeks both damages and injunctive relief through those claims. A two-week jury trial is currently scheduled for February 9, 2009. The Company does not expect the ultimate resolution of this matter will have a material adverse impact on its business.

        Although the Company is subject to other litigation from time to time in the ordinary course of its business, the Company is not party to any other pending legal proceedings that the Company believes will have a material adverse impact on its business.

        As of September 30, 2007, the Company has not accrued any amounts related to estimated losses for legal contingencies. While there is a reasonable possibility that certain legal matters may result in an unfavorable outcome and loss, the Company's estimated potential losses, or range of losses, when aggregated, is immaterial to the financial statements.

15

13. SUBSEQUENT EVENTS

        On November 1, 2007, the Board of Directors of the Company approved an authorization to repurchase up to one million shares of its common stock. Share repurchases under this authorization may be made in the open market or in privately negotiated transactions. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase authorization does not have an expiration date and does not obligate the Company to acquire any particular amount of shares of its common stock. The repurchase authorization may be modified, suspended or discontinued at any time. On November 7, 2007, the Company repurchased approximately 524,000 shares for a total of approximately $25.0 million.

        The Company and Ronald Snyder, President and Chief Executive Officer, and Peter Case, Chief Financial Officer, have been named as defendants in a complaint filed by an investor in the United States District Court for the District of Colorado on November 8, 2007. The complaint purports to be brought on behalf of a class of all persons who purchased the Company's stock in the market between July 27, 2007 and October 31, 2007 (the "Class Period"). The complaint alleges that defendants made false and misleading public statements about the Company, and its business and prospects, in press releases and at investor conferences during the Class Period, and that the market price of the Company's stock was artificially inflated as a result. The complaint alleges claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934. It seeks compensatory damages on behalf of the alleged class in an unspecified amount, interest, and an award of attorneys' fees and costs of litigation. The Company is unable, at this time, to estimate any potential losses related to this matter.

        The Company and the other defendants have not yet responded to the complaint, but intend to vigorously defend the action. The Company is not able to predict the ultimate outcome of the action. It is possible that it could be resolved adversely to the Company, could result in substantial costs, and could divert management's attention and resources which could harm the Company's business.

16

ITEM 2.    Management's Discussion and Analysis of Financial Condition and Results of Operations

Forward-Looking Statements

        This quarterly report on Form 10-Q contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. In addition, the Company may make other written and oral communications from time to time that contain such statements. Forward-looking statements include statements as to company and industry trends, future expectations of the Company and other matters that do not relate strictly to historical facts and are based on certain assumptions by management. These statements are often identified by the use of words such as "may," "will," "expect," "believe," "anticipate," "intend," "could," "estimate," or "continue," and similar expressions or variations. These statements are based on the beliefs and assumptions of the management of the Company based on information currently available to management. Such forward-looking statements are subject to risks, uncertainties and other factors that could cause actual results to differ materially from future results expressed or implied by such forward looking statements. These forward-looking statements include statements in this Item 2, "Management Discussion and Analysis of Financial Condition and Results of Operations." Important factors that could cause actual results to differ materially from the forward-looking statements include, among others, the risks described in the section entitled "Risk Factors" under Item 1A in our Annual Report on Form 10-K for the year ended December 31, 2006 and in Part II Section 1A below. We caution the reader to carefully consider such factors. Furthermore, such forward-looking statements speak only as of the date of this report. We undertake no obligation to update any forward-looking statements to reflect events or circumstances after the date of such statements.

Overview

        We are a rapidly growing designer, manufacturer, and marketer of footwear for men, women, and children. All of our Crocs-branded footwear products incorporate croslite, which enables us to produce a soft and lightweight, non-marking, slip- and odor-resistant shoe that retails at attractive price points. In addition to our footwear products, we own Jibbitz, a unique accessory brand with colorful snap-on products specifically suited for Crocs shoes, and introduced a line of Crocs-branded apparel and accessory items. We also own Fury, which produces and distributes hockey and lacrosse equipment for adults and children, and EXO, an Italian designer and producer of EVA (Ethylene Vinyl Acetate) based finished products, primarily for the footwear industry. In January 2007, we acquired substantially all of the assets of Ocean Minded, a design and manufacturer of high quality leather and EVA based sandals primarily for the beach, adventure and action sports market. In July 2007, we acquired Bite, a design and manufacturer of comfortable and supportive performance shoes and sports sandals sold worldwide in five categories including, golf, adventure, healthy lifestyle, travel and watersports. We also use croslite to manufacture non-branded products that we sell to original equipment manufacturers.

        We currently sell our Crocs-branded products throughout the U.S. and in over 90 countries worldwide. We sell our products directly to retailers or through distributors where we believe they offer a preferable alternative to direct sales. We also sell directly to consumers through our website and our company-operated kiosks and retail stores. The broad appeal of our footwear has allowed us to market our products to a wide range of distribution channels in the U.S., including traditional footwear retailers as well as a variety of specialty channels. As of September 30, 2007, our retail customer base domestically and international included over 12,500 and 16,000 sales locations selling our products, respectively.

        We have achieved significant growth since our inception, driven largely by the popularity of our footwear products and our ability to significantly expand the breadth and depth of our distribution network and manufacturing capacities. For the quarter ended September 30, 2007, we recorded revenues of $256.3 million and net income of $56.5 million, compared to $111.3 million of revenues

17

and net income of $21.5 million for the quarter ended September 30, 2006. We have also achieved strong gross profit margins on sales of our Crocs footwear. For the quarter ended September 30, 2007, our gross profit was $155.4 million, or 60.6% of revenues, compared to $64.8 million, or 58.2% of revenues, for the quarter ended September 30, 2006. We believe a number of factors have contributed to our ability to achieve gross profit margins at these levels including our use of third party manufacturers, addition of products with higher margins, and international sales. Our company-operated manufacturing facilities have allowed us to maintain a relatively low cost structure while enabling us to achieve significant production flexibility and decrease lead times to our respective markets.

General

        Revenues are recorded when products are shipped and the customer takes title and assumes risk of loss, collection of related receivables are probable, persuasive evidence of an arrangement exists and the sales price is fixed or determinable. Title passes on shipment or on receipt by the customer depending on the country of the sale and the agreement with the customer. Allowances for estimated returns and discounts are recognized when related revenue is recorded. Because we use internal manufacturing and also contract with third parties to manufacture our products, our cost of sales represents our costs to manufacture products in our own facilities, including raw materials costs and all overhead expenses related to production, as well as the cost to purchase finished products from our third party manufacturers. Cost of sales also includes the cost to transport these products to our facilities and all warehouse and outbound freight expenses. Our selling, general and administrative expense consists primarily of selling, marketing, wages and related payroll and employee benefit costs, travel and insurance expenses, research and development costs, depreciation, amortization, professional fees, facility expenses, bank charges and non-cash charges for stock based compensation, net of those allocated to cost of sales.

Results of Operations

Three Months Ended September 30, 2007 Compared to Three Months Ended September 30, 2006

        Revenues.    Revenues increased 130% or $145 million, to $256.3 million, in the three months ended September 30, 2007, from $111.3 million in the three months ended September 30, 2006. Our revenues from sales outside of the United States were $130.9 million in the three months ended September 30, 2007 compared to $40.9 million in the three months ended September 30, 2006. This increase was primarily a result of significantly higher unit sales of our footwear products in our domestic, Asian and European markets driven by growing awareness and increased acceptance of our brands and products. Sales in Europe increased 392% or $46.3 million, to $58.1 million in the three months ended September 30, 2007, from $11.8 million in the three months ended September 30, 2006. Asia sales increased 240% or $38.1 million, to $53.9 million in the three months ended September 30, 2007, from $15.8 million in the three months ended September 30, 2006. Sales in Asia were led by Japan where sales increased 630% or $27.1 million, to $31.4 million in the three months ended September 30, 2007, from $4.3 million in the three months ended September 30, 2006. Unit sales of footwear products increased 103% or 7.0 million pairs, to 13.8 million pairs, in the three months ended September 30, 2007, from 6.8 million pairs in the three months ended September 30, 2006. The higher unit sales resulted from

•

an increase in the number of retail stores selling our products,



•

new product offerings,



•

increased sales at retail locations owned by us and through our webstores, and



•

expansion of direct sales into new markets, including China, Brazil and India.

18

        Domestic and international retail stores selling our products totaled over 12,500 and 16,000, respectively, at September 30, 2007 compared to over 9,000 and 6,500, respectively, at September 30, 2006. Sales of our classic models increased by approximately 40% during the three months ended September 30, 2007 when compared to sales in the three months ended September 30, 2006 and now amounts to 35% of total sales. Sales of new 2007 footwear product lines represented approximately 18% of our overall revenues for the three months ended September 30, 2007,

        Our company owned retail locations, including retail stores, kiosks and outlets, increased to over 185 at September 30, 2007 from just over 70 at September 30, 2006. We expect revenues from our company owned retail stores to increase in the future as we continue to expand the number of company owned retail locations.

        Gross profit.    Gross profit increased 140% or $90.6 million, to $155.4 million, in the three months ended September 30, 2007, from $64.8 million in the three months ended September 30, 2006. Our gross profit margin improved by 240 basis points to 60.6% in the three months ended September 30, 2007, compared to 58.2% in the three months ended September 30, 2006. This increase in margin was primarily attributable to increases in direct and international sales and the addition of Jibbitz because we recognize higher margins on these sales. We expect the gross margin rate to decrease in future periods as we expand our operations and sell products with higher duty rates and lower margins.

        Selling, general and administrative expenses.    Selling, general and administrative expense increased 131% or $43.9 million, to $77.2 million in the three months ended September 30, 2007, from $33.3 million in the three months ended September 30, 2006. As a percentage of revenues, selling, general and administrative expenses increased 20 basis points to 30.1% for the three months ended September 30, 2007 from 29.9% for the three months ended September 30, 2006. This increase was primarily a result of higher costs associated with increased sales volumes, including an increase in selling and marketing expenses of $14.3 million related to our increase in corporate sponsorships such as the AVP Crocs Tour, advertising and college sponsorships, and increases in personnel expenses of $18.0 million due to our growth and expanding operations. In addition, professional and consulting fees increased approximately $7.8 million, as a result of increased legal expenses related to defending the International Trade Commission ("ITC") litigation, accounting and consulting fees related to our efforts to comply with the Sarbanes-Oxley Act of 2002, and improve information and technology systems. The increase in retail locations owned by us resulted in increased selling, general and administrative expenses as we incurred additional personnel and operating expenses associated with operating the retail stores. We anticipate that selling, general and administrative expenses will continue to increase as revenues grow. Selling, general and administrative expenses, as a percentage of sales, may increase as the result of the addition of Company owned retail locations that typically have higher selling, general and administrative expenses as a percentage of sales.

        Interest expense.    Interest expense was $191,000 in the three months ended September 30, 2007, compared to $162,000 in the three months ended September 30, 2006.

        Other income, net.    Other income was $1.2 million in the three months ended September 30, 2007, compared to $657,000 in the three months ended September 30, 2006. The increase resulted primarily from a refund due to a change in our tax filing position related to value added taxes in our international locations.

        Income tax expense.    During the three months ended September 30, 2007, income tax expense was $22.7 million, representing an effective income tax rate of 28.6%, compared to income tax expense of $10.4 million, representing an effective income tax rate of 32.7% in the three months ended September 30, 2006. The decrease of 410 basis points relates primarily to an increase in the pre-tax earnings in jurisdictions with lower relative income tax rates as a percentage of total pre-tax earnings.

19

Nine Months Ended September 30, 2007 Compared to Nine Months Ended September 30, 2006

        Revenues.    Revenues increased 158% or $380.8 million, to $622.6 million, in the nine months ended September 30, 2007, from $241.8 million in the nine months ended September 30, 2006. In addition, our revenues from sales outside of the United States were $298.8 million in the nine months ended September 30, 2007 compared to $78.4 million in the nine months ended September 30, 2006. This increase was primarily a result of significantly higher unit sales of our footwear products in our domestic, Asian and European markets driven by growing awareness and increased acceptance of our brands and products. Sales in Europe increased 593% or $115.0 million, to $134.4 million in the nine months ended September 30, 2007, from $19.4 million in the nine months ended September 30, 2006. Asia sales increased 233% or $77.3 million, to $110.4 million in the nine months ended September 30, 2007, from $33.1 million in the nine months ended September 30, 2006. The higher unit sales of our footwear products resulted from:

•

an increase in the number of retail stores selling our products,



•

new product offerings,



•

increased sales at retail locations owned by us and through our webstores, and



•

expansion of direct sales into new markets, including China, Brazil and India.

        Domestic and international retail stores selling our products totaled over 12,500 and 16,000, respectively, at September 30, 2007, compared to over 9,000 and 6,500, respectively, at September 30, 2006. Sales of our classic models increased by approximately 63% during the nine months ended September 30, 2007 when compared to sales in the nine months ended September 30, 2006 and now amounts to 34% of total sales. Sales of new footwear product lines represented approximately 14% of our overall revenues for the nine months ended September 30, 2007.

        Our company owned retail locations, including retail stores, kiosks and outlets, increased to over 185 at September 30, 2007 from just over 70 at September 30, 2006. We expect revenues from our company owned retail stores to increase in the future as we continue to expand the number of company owned retail locations.

        Gross profit.    Gross profit increased 174% or $236.3 million, to $371.8 million, in the nine months ended September 30, 2007, from $135.5 million in the nine months ended September 30, 2006. Our gross profit margin improved by 370 basis points to 59.7% in the nine months ended September 30, 2007, compared to 56.0% in the nine months ended September 30, 2006. This increase in margin was primarily attributable to increases in direct and international sales and the addition of Jibbitz as we recognize higher margins on these sales. We expect the gross margin rate to decrease in future periods as we expand our operations and sell products with higher duty rates and lower margins.

        Selling, general and administrative expense.    Selling, general and administrative expense increased 168% or $117.7 million, to $188 million in the nine months ended September 30, 2007, from $70.3 million in the nine months ended September 30, 2006. This increase was primarily a result of higher costs required to support increased sales volumes, including increases in personnel expenses of $57.2 million (including share-based compensation), increases in selling and marketing expenses of $34.9 million, and increases in professional fees of $18.6 million, primarily as a result of increased legal expenses related to defending the ITC litigation, accounting and consulting fees related to our efforts to comply with the Sarbanes-Oxley Act of 2002, and improve information and technology systems. In addition, depreciation and amortization expense increased $4.7 million, due to the increase in capital expenditures and intangible assets associated with the acquisitions of Jibbitz, Fury, EXO, Ocean Minded and Bite. As a percentage of revenues, selling, general and administrative expense increased to 30.2% in the nine months ended September 30, 2007, from 29.1% in the nine months ended September 30, 2006, as we hired additional personnel and incurred increased costs related to our

20

growth. The increase in retail locations owned by us resulted in increased selling, general and administrative expenses as we incurred additional personnel and operating expenses associated with operating the retail stores. We anticipate that selling, general and administrative expenses will continue to increase as revenues grow. Selling, general and administrative expenses, as a percentage of sales, may increase as the result of the addition of Company owned retail locations that typically have higher selling, general and administrative expenses as a percentage of sales.

        Interest expense.    Interest expense was $306,000 in the nine months ended September 30, 2007, compared to $533,000 in the nine months ended September 30, 2006. Interest expense decreased due to our use of a portion of the proceeds from our initial public offering to retire bank loans. This debt retirement led to a decrease in average borrowings outstanding on our line of credit and long term debt during the nine months ended September 30, 2007 compared to average borrowings outstanding under those arrangements during the nine months ended September 30, 2006.

        Other income, net.    Other income was $2.1 million in the nine months ended September 30, 2007, compared to income of $1.3 million in the nine months ended September 30, 2006. The increase resulted primarily from a refund due to a change in our tax filing position related to value added taxes in our international locations.

        Income tax expense.    During the nine months ended September 30, 2007, income tax expense was $55.7 million, representing an effective income tax rate of 30.0%, compared to income tax expense of $22.3 million, representing an effective income tax rate of 33.8% in the nine months ended September 30, 2006. The decrease relates primarily to an increase in the pre-tax earnings in jurisdictions with lower income tax rates as a percentage of total pre-tax earnings.

Liquidity and Capital Resources

        As of September 30, 2007, we had $76.6 million in cash and cash equivalents and short-term investments compared to $67.9 million as of December 31, 2006. In the nine months ended September 30, 2007, we used, $41.6 million for capital expenditures related to increasing our manufacturing capacity and improving our infrastructure, $14.2 million to expand and upgrade our existing information technology systems, and $11.3 million for acquisitions, net of cash received.

        The significant components of our working capital are cash, accounts receivable, inventory, accounts payable and accrued expenses. Capital requirements related to manufacturing include compounding and injection molding equipment for facilities we operate, as well as footwear molds and equipment used in our company-operated facilities or purchased for use by our third party manufacturers.

        Cash provided by operating activities consists primarily of net income adjusted for certain non-cash items including depreciation, amortization, deferred income taxes, provision for bad debts, stock-based compensation and changes in working capital and other activities. Cash provided by operating activities in the nine month period ended September 30, 2007 was $22.2 million and was primarily related to net income of $129.9 million plus non-cash items of depreciation and amortization of $13.6 million, share-based compensation of $16.0 million and increases in accounts payable and accrued liabilities of $113.9 million, partially offset by increases in working capital resulting from increases in inventory of $101.7 million and accounts receivable of $92.1million. Cash provided by operating activities in the nine month period ended September 30, 2006 was $3.4 million and was primarily related to net income of $43.6 million plus non-cash items of depreciation and amortization of $5.2 million, share-based compensation expense of $7.2 million and an increase in accounts payable and accrued liabilities of $23.3 million, which was offset by increases in working capital resulting from increases in accounts receivable of $43.7 million and inventory of $20.4 million.

21

        At September 30, 2007 our inventories were $195.3 million, an increase of $109.1 million when compared to the inventories of $86.2 million at December 31, 2006. During the quarter ended September 30, 2007, we increased our inventory positions primarily in core styles in order to meet anticipated demand for the nine months ending June 30, 2008 and, at the same time, make available production capacity for new product lines for delivery in the quarters ending December 31, 2007 and March 31, 2008, respectively. Management expects that new product introductions, production capacities and seasonal variations may cause our inventory to increase or decrease materially in the future as we adjust to meeting changing conditions resulting from our rapid growth and ongoing expansion.

        We anticipate that operating activities will continue to provide cash in the future. However, seasonal variations in product demand and the associated changes in operating assets and liabilities in response to such seasonal variations may directly affect our cash flows from operating activities. Accordingly, cash flows from operating activities for any one quarter are not necessarily indicative of cash flows from operating activities to be expected for any other quarter.

        Cash used in investing activities for the nine months ended September 30, 2007 was $62.5 million, which resulted from capital expenditures for molds, machinery and equipment of $41.6 million, $14.2 million related to the upgrade and expansion of our information technology systems and $11.3 million for acquisitions, net of cash received. Cash used in investing activities in the nine months ended September 30, 2006 was $39.8 million, which resulted from net purchases of investments of $25.4 million, capital expenditures of $13.0 million and $1.7 million related to the upgrade and expansion of our information technology systems. We expect that we will continue to invest cash in our manufacturing and information technology systems to enhance and further develop our production capacity and global infrastructure to support the growth of the business and retail sales.

        Cash provided by financing activities was $52.0 million for the nine months ended September 30, 2007, which resulted from exercises of stock options of $14.0 million and excess tax benefit on share-based compensation of $38.6 million. Cash provided by financing activities was $89.5 million for the nine months ended September 30, 2006, which resulted from the completion of the initial public offering of our common stock whereby we received net proceeds of $94.5 million, after deducting underwriting discounts and commissions and related offering costs, offset by payments on long-term debt and capital lease obligations of $12.0 million.

        On June 26, 2007 we amended the membership interest purchase agreement with Jibbitz, LLC ("Jibbitz") (Purchase Agreement) to amend the terms of the potential earn-out consideration included in the Purchase Agreement. The amendment removed the earnings targets for payment of the earn-out with $3.5 million payable on the effective date of the amended Purchase Agreement and the remaining $6.5 million payable over the following thirteen months, for a total payment of $10.0 million. We have $4.9 million in remaining accrued additional purchase price for Jibbitz as of September 30, 2007, which is to be paid out in monthly payment installments over the ten month period ending July 2008.

        On November 1, 2007, our Board of Directors approved an authorization to repurchase up to one million shares of our common stock. Share repurchases under this authorization may be made in the open market or in privately negotiated transactions. The timing and actual number of shares repurchased will depend on a variety of factors including price, corporate and regulatory requirements and other market conditions. The repurchase authorization does not have an expiration date and does not obligate us to acquire any particular amount of shares of our common stock. The repurchase authorization may be modified, suspended or discontinued at any time. On November 7, 2007, we repurchased approximately 524,000 shares for a total of approximately $25.0 million.

        We anticipate that cash flows from operations, together with cash flows from stock option exercises, will be sufficient to meet or exceed the ongoing needs of our existing business. As of September 30, 2007, we have a line of credit with a bank in the amount of $15.0 million that is used

22

primarily as collateral for letters of credit issued to certain of our vendors. We may, in the future, enter into additional borrowing arrangements should additional liquidity be required to fund future acquisitions, other investment opportunities, or repurchase additional shares of our common stock.

Seasonality

        Due to our significant sales growth since our inception, we cannot assess with certainty the degree to which sales of our footwear products will be subject to seasonality. However, we expect that our business, similar to other vendors of footwear and related merchandise, will be subject to seasonal variation. We believe many vendors that market footwear products suited for warm weather normally experience their highest sales activity during the second and third quarters of the calendar year. While we have introduced footwear models that are more suitable for cold weather uses, such as the Mammoth, Endeavor, Georgie, All Terrain, Snowmini, and YOU by Crocs^tm, we expect demand for our products, and therefore our sales, may be subject to seasonal variations and significantly impacted by weather conditions because over 75% of our revenues during the three months ended September 30, 2007, were attributable to our footwear styles more suitable for fair weather. In addition, our quarterly results of operations may fluctuate significantly as a result of a variety of other factors, including the timing of new model introductions or general economic or consumer conditions. Accordingly, results for any one quarter are not necessarily indicative of results to be expected for any other quarter or for any year, and revenues for any particular period may fluctuate.

Critical Accounting Policies and Estimates

        Our accounting policies and accounting estimates critical to our financial condition and results of operations are set forth in our Annual Report on Form 10-K for the year ended December 31, 2006. We have not modified the policies and estimates set forth in our Annual Report on Form 10-K for the year ended December 31, 2006, except for the accounting for the adoption of FIN 48.

Income Taxes

        In July 2006, the Financial Accounting Standards Board ("FASB") issued FASB Interpretation No. 48, "Accounting for Uncertainty in Income Taxes" ("FIN 48"). FIN 48 clarifies the accounting for uncertainty in income taxes recognized in an enterprise's financial statements in accordance with FASB Statement No. 109, "Accounting for Income Taxes." FIN 48 prescribes a recognition threshold and measurement attribute for the financial statement recognition and measurement of a tax position taken or expected to be taken in a tax return. FIN 48 also provides guidance on derecognition, classification, interest and penalties, accounting in interim periods, disclosure and transition and was effective beginning January 1, 2007. There was no cumulative effect of the adoption of FIN 48.

        Our annual tax rate is based on our income, statutory tax rates and tax planning opportunities available to us in the various jurisdictions in which we operate. Significant judgment is required in determining our annual tax expense and in evaluating our tax positions. We establish reserves at the time we determine it is probable we will be liable to pay additional taxes related to certain matters. We adjust these reserves, including any impact on the related interest and penalties, in light of changing facts and circumstances, such as the progress of a tax audit.

        Tax laws require items to be included in our tax returns at different times than when these items are reflected in the consolidated financial statements. As a result, the annual tax rate reflected in our consolidated financial statements is different than that reported in our tax return (our cash tax rate). Some of these differences are permanent, such as expenses that are not deductible in our tax return, and some differences reverse over time, such as depreciation expense. These timing differences create deferred tax assets and liabilities. Deferred tax assets and liabilities are determined based on temporary differences between the financial reporting and tax bases of assets and liabilities. The tax rates used to

23

determine deferred tax assets or liabilities are the enacted tax rates in effect for the year in which the differences are expected to reverse. Based on the evaluation of all available information, we recognize future tax benefits, such as net operating loss carryforwards, to the extent that realizing these benefits is considered more likely than not.

        We evaluate our ability to realize the tax benefits associated with deferred tax assets by analyzing our forecasted taxable income using both historical and projected future operating results, the reversal of existing temporary differences, taxable income in prior carryback years (if permitted) and the availability of tax planning strategies. A valuation allowance is required to be established unless management determines that it is more likely than not that we will ultimately realize the tax benefit associated with a deferred tax asset.

        Additionally, undistributed earnings of a subsidiary are accounted for as a temporary difference, except that deferred tax liabilities are not recorded for undistributed earnings of a foreign subsidiary that are deemed to be indefinitely reinvested in the foreign jurisdiction. We have formulated a specific plan for reinvestment of undistributed earnings of its foreign subsidiaries which demonstrates that such earnings will be indefinitely reinvested in the applicable tax jurisdictions. Should we change our plans, we would be required to record a significant amount of deferred tax liabilities.

ITEM 3.    Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

        We earn interest income on both our cash and cash equivalents and our investment portfolio. Our investment portfolio generally consists of readily marketable investment-grade debt securities of various issuers and maturities. All investments are denominated in U.S. dollars and are classified as "available for sale." These instruments are not leveraged, and are not held for trading purposes. We have performed a sensitivity analysis to estimate our exposure to market risk of interest rates, and if the weighted average rate of return on cash and cash equivalents, restricted cash, and marketable securities were to increase or decrease by 1%, the impact on interest income would be $141,000, net of tax during the three months ended September 30, 2007.

Credit Risk

        We do not have any variable rate debt instruments, and we are not exposed to market risk due to changes in interest rates such as the prime rate and LIBOR.

Foreign Currency Exchange Risk

        We pay the majority of our overseas third party manufacturers in U.S. dollars and have had significant revenues from foreign sales in recent periods. Our ability to sell our products in foreign markets and the U.S. dollar value of the sales made in foreign currencies can be significantly influenced by foreign currency fluctuations. A decrease in the value of foreign currencies relative to the U.S. dollar could result in downward price pressure for our products or losses from currency exchange rates. We have performed a sensitivity analysis to estimate our exposure to market risk of foreign exchange rates. If the U.S. dollar were to increase or decrease in value by 1%, the impact on international sales of $130.9 million during the three months ended September 30, 2007 would have been an increase or decrease in consolidated revenues by $934,000, net of tax. The volatility of the applicable rates and prices are dependent on many factors that cannot be forecast with reliable accuracy. In the event our foreign sales and purchases increase and are denominated in currencies other than the U.S. dollar, our operating results may be affected by fluctuations in the exchange rate of currencies we receive for such sales. We may engage in forward foreign exchange contracts to reduce our economic exposure to changes in exchange rates. Forward contracts are entered into to hedge specific commitments and anticipated transactions but not for speculative or trading purposes.

24

ITEM 4.    Controls and Procedures

        Our management has evaluated, under the supervision and with the participation of our Chief Executive Officer and Chief Financial Officer, the effectiveness of our disclosure controls and procedures as of the end of the period covered by this report pursuant to Rule 13a-15(b) under the Securities Exchange Act of 1934. Based on that evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of September 30, 2007, our disclosure controls and procedures are effective in ensuring that information required to be disclosed in our Exchange Act reports is (1) recorded, processed, summarized and reported in a timely manner, and (2) accumulated and communicated to our management, including our Chief Executive Officer and Chief Financial Officer, as appropriate to allow timely decisions regarding required disclosure.

        We are currently undergoing a comprehensive effort in preparation for compliance with Section 404 of the Sarbanes-Oxley Act of 2002. This effort includes the documentation, testing and review of our internal controls under the direction of senior management. During the course of these activities, we have identified certain opportunities to improve our internal controls over financial reporting. As a result, we are evaluating and implementing improvements to our internal controls over financial reporting and will continue to do so. These improvements include further formalization of accounting standards and guidelines, improved segregation of duties, hiring additional competent accounting managers and staff, and improving information technology system controls. Any further opportunities to improve our internal controls identified by our continued compliance efforts will be addressed accordingly.

        During the three months ended September 30, 2007, we made changes to our internal control over financial reporting that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting. In August and September 2007, we implemented a new accounting and operational software package at our subsidiaries in Canada and Japan respectively. Certain processes and controls were changed to accommodate the needs and requirements of our growth and the new financial reporting system.

25

PART II.
OTHER INFORMATION

ITEM 1.    Legal Proceedings

        We and two of our executive officers have been named as defendants in a complaint filed by an investor in the United States District Court for the District of Colorado on November 8, 2007. The complaint purports to be brought on behalf of a class of all persons who purchased our stock in the market between July 27, 2007 and October 31, 2007 (the "Class Period"). The complaint alleges that defendants made false and misleading public statements about our company, and our business and prospects, in press releases and at investor conferences during the Class Period, and that the market price of our stock was artificially inflated as a result. The complaint alleges claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934. It seeks compensatory damages on behalf of the alleged class in an unspecified amount, interest, and an award of attorneys' fees and costs of litigation.

        We and the other defendants have not yet responded to the complaint, but intend to vigorously defend the action. We are not able to predict the ultimate outcome of the action. It is possible that it could be resolved adversely to us, could result in substantial costs, and could divert management's attention and resources, which could harm our business.

        On April 3, 2006, we filed a complaint in the U.S. District Court for the District of Colorado alleging patent and trade dress infringement and seeking injunctive relief against Acme EX-IM, Inc., Australia Unlimited, Inc., Cheng's Enterprises, Inc., Collective Licensing International, LLC, D. Myers & Sons, Inc., Double Diamond Distribution, Ltd., Effervescent, Inc., Gen-X Sports, Inc., Holey Soles Holdings, Ltd., Inter-Pacific Trading Corporation, Shaka Holdings, Inc., and Does 1-10. The utility and design patents asserted in the complaint were issued to us on February 7, 2006 and March 28, 2006 respectively, by the United States Patent and Trademark Office. Consent judgments have been entered against Shaka Holdings, Inc., Interpacific Trading Corporation and Acme Ex-Im, Inc. We have entered into a settlement agreement with Australia Unlimited, Inc., and, on January 25, 2007, filed a stipulation for dismissal of all claims and counterclaims. We have entered into a settlement agreement with D. Myers & Sons, Inc. and, on May 23, 2007, the U.S. District Court entered a consent judgment against D. Myers & Sons, Inc. We do not expect the ultimate resolution of this matter will have a material adverse impact on our business.

        Although we are subject to litigation from time to time in the ordinary course of our business, we are not party to any pending legal proceedings that we believe would have a material adverse impact on our business.

ITEM 1A.    Risk Factors

        We had the following changes to the risk factors contained in our Annual Report on Form 10-K for the year ended December 31, 2006. In addition to the other information set forth in this report, you should carefully consider the factors discussed in Part I, "Item 1A. Risk Factors" in our Annual Report on Form 10-K for the year ended December 31, 2006, which could materially affect our business, financial condition or future results. The risks described in our Annual Report on Form 10-K are not the only risks facing our Company. Additional risks and uncertainties not currently known to us or that we currently deem to be immaterial also may materially adversely affect our business, financial condition and/or operating results.

We have been named as a defendant in a securities class action lawsuit that may result in substantial costs and could divert management's attention.

        We and two of our executive officers have been named as defendants in a complaint filed by an investor in the United States District Court for the District of Colorado on November 8, 2007. The

26

complaint purports to be brought on behalf of a class of all persons who purchased our stock in the market between July 27, 2007 and October 31, 2007 (the "Class Period"). The complaint alleges that defendants made false and misleading public statements about our company, and our business and prospects, in press releases and at investor conferences during the Class Period, and that the market price of our stock was artificially inflated as a result. The complaint alleges claims under Section 10(b) and Section 20(a) of the Securities Exchange Act of 1934. It seeks compensatory damages on behalf of the alleged class in an unspecified amount, interest, and an award of attorneys' fees and costs of litigation.

        We are not able to predict the ultimate outcome of the action. It is possible that it could be resolved adversely to us, could result in substantial costs, and could divert management's attention and resources, which could harm our business. Risks associated with legal liability are often difficult to assess or quantify, and their existence and magnitude can remain unknown for significant periods of time. While we maintain director and officer insurance, the amount of insurance coverage may not be sufficient to cover a claim and the continued availability of this insurance cannot be assured. We may in the future be the target of additional proceedings, and these proceedings may result in substantial costs and divert management's attention and resources that are needed to successfully run our business.

We may fail to meet analyst expectations, which could cause the price of our stock to decline.

        Our common stock is traded publicly and various securities analysts follow our financial results and issue reports on us. These reports include information about our historical financial results as well as the analysts' estimates of our future performance. The analysts' estimates are based upon their own opinions and are often different from our estimates or expectations. If our operating results are below the estimates or expectations of public market analysts and investors, our stock price could decline. Recently, a securities class action litigation was brought against us and such actions are frequently brought against other companies following a decline in the market price of their securities. If our stock price is volatile, we may become involved in this type of litigation in the future. Any litigation could result in substantial costs and a diversion of management's attention and resources that are needed to successfully run our business.

ITEM 4.    Submission of Matters to a Vote of Security Holders.

        At the annual meeting of stockholders held on July 9, 2007 the following matters were submitted to a vote. The record date for the annual meeting of stockholders was May 31, 2007, as such, the following votes do not reflect the two-for-one stock split of our common stock that occurred on June 14, 2007.

1.

Election of three Class II directors to serve for a three year term expiring at the 2010 annual meeting of stockholders:

	In Favor	Withheld
Raymond D. Croghan	33,183,661	1,463,582
Michael E. Marks	33,008,284	1,638,959
Richard L. Sharp	33,066,187	1,581,056

Our continuing directors are Ronald L. Frash (Class I), Marie Holman-Rao (Class I), Thomas J. Smach (Class III), and Ronald R. Snyder (Class III).

2.

Approval of the Crocs, Inc. 2008 Cash Incentive Plan:

Affirmative votes	33,449,489
Negative votes	455,453
Abstain	743,301

27

3.

Approval of the Crocs, Inc. 2007 Cash Incentive Plan:

Affirmative votes	33,330,261
Negative votes	573,798
Abstain	743,184

4.

Approval of the Crocs, Inc. 2007 Equity Incentive Plan:

Affirmative votes	14,069,071
Negative votes	10,895,241
Abstain	777,930
Non-votes	8,905,001

5.

Approval of the Amendment to the Restated Certificate of Incorporation of Crocs, Inc. to increase the number of authorized shares of Capital stock from 130,000,000 to 255,000,000:

Affirmative votes	31,394,042
Negative votes	2,563,121
Abstain	690,080

6.

Ratification of the appointment of Deloitte & Touche LLP as our independent registered public accounting firm for fiscal year 2007:

Affirmative votes	25,042,217
Negative votes	21,173
Abstain	678,852
Non-votes	8,905,001

28

ITEM 6.    Exhibits

Exhibit List

Exhibit Number	Description
3.1**	Restated Certificate of Incorporation of Crocs, Inc.
3.2@	Certificate of Amendment to the Restated Certificate of Incorporation of Crocs, Inc.
3.3**	Amended and Restated Bylaws of Crocs, Inc.
4.1*	Specimen common stock certificate.
10.1††	Form of Incentive Stock Option Agreement under the 2007 Plan.
10.2††	Form of Non-Statutory Stock Option Agreement under the 2007 Plan.
10.3††	Form of Non-Statutory Stock Option Agreement for Non-Employee Directors under the 2007 Plan.
31.1††	Certification of the Chief Executive Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act.
31.2††	Certification of the Chief Financial Officer pursuant to Rule 13a-14(a) or Rule 15d-14(a) of the Securities Exchange Act of 1934 as adopted pursuant to Section 302 of the Sarbanes-Oxley Act.
32††	Certification of the Chief Executive Officer and Chief Financial Officer pursuant to 18 USC. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act.

*

Incorporated herein by reference to Crocs, Inc.'s Registration Statement on Form S-1 (File No. 333-127526).

**

Incorporated by reference to Crocs, Inc.'s Registration Statement on Form S-8, filed on March 9, 2006 (File No. 333-132312).

@

Incorporated by reference to Crocs, Inc.'s Current Report on Form 8-K, filed on July 12, 2007 (File No. 000-51754).

††

Filed herewith.

29

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

	CROCS, INC.
Date: November 14, 2007	By:	/s/  PETER S. CASE
		Name:	Peter S. Case
		Title:	Chief Financial Officer, Senior Vice President—Finance and Treasurer

30

EX-10.1

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 10.1

CROCS, INC.
2007 EQUITY INCENTIVE PLAN

Incentive Stock Option Agreement

Name of Participant:
Number of Shares Covered:	Grant Date:
Exercise Price Per Share:	Expiration Date:
Exercise Schedule (Cumulative):

This is an Incentive Stock Option Agreement ("Agreement") between Crocs, Inc., a Delaware corporation (the "Company"), and you, the Participant identified above, effective as of the Grant Date specified above.

Recitals*

        A.    The Company maintains the Crocs, Inc. 2007 Equity Incentive Plan (the "Plan"); and

        B.    Pursuant to the Plan, the Compensation Committee of the Board of Directors (the "Committee") administers the Plan, has the authority to determine the awards to be granted under the Plan and, subject to certain limitations contained in the Plan, has the authority to delegate such authority to persons who are not Non-Employee Directors of the Company; and

        C.    The Committee, either acting on its own or through certain of its authorized delegates, has determined that you are eligible to receive an award under the Plan in the form of an Incentive Stock Option (the "Option");

        NOW, THEREFORE, the Company hereby grants this Option to you subject to the following terms and conditions:

Terms and Conditions

1.

Grant. You are granted this Option to purchase the number of Shares specified at the beginning of this Agreement.

2.

Exercise Price. The purchase price to you of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement, which price shall not be less than the Fair Market Value of a Share as of the Grant Date.

3.

Non-Statutory Stock Option. This Option is intended to be an "incentive stock option" within the meaning of Section 422 of the Code, and shall not be an "incentive stock option" to the extent it does not so qualify. The terms of this Agreement and the Plan shall be interpreted and administered so as to satisfy the requirements of the Code.

4.

Exercise Schedule. This Option shall vest and become exercisable in accordance with the schedule specified at the beginning of this Agreement. The exercise schedule is cumulative, meaning that to the extent this Option has not been exercised and has not expired, terminated or been cancelled, it may be exercised with respect to any or all of the Shares as to which this Option has vested and become exercisable.

The vesting of this Option may be accelerated and it may be exercised in full under the circumstances described in Section 8 of this Agreement if it has not expired prior thereto.

*

Unless the context clearly indicates otherwise, any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future

5.

Expiration. This Option shall expire at 5:00 p.m. Mountain Time on the earliest of:

(a)

The Expiration Date specified at the beginning of this Agreement, which shall not be later than ten years after the Grant Date;

(b)

The last day of the period following the termination of your employment during which this Option can be exercised (as specified in Section 7 of this Agreement);

(c)

The date your employment is terminated through discharge for Cause; or

(d)

The date (if any) fixed for cancellation pursuant to Section 8 of this Agreement.

No one may exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.

6.

Procedure to Exercise Option.

Notice of Exercise. This Option may be exercised by delivering advance written notice of exercise to the Company at its headquarters in the form attached to this Agreement or in such other form as may be approved by the Company from time to time or by notifying the Company's outside Plan administrator of your intent to exercise and complying with all requirements set forth by such outside Plan administrator. If the person exercising this Option is not you, he/she also must submit appropriate proof of his/her right to exercise this Option.

Tender of Payment. Upon giving notice of any exercise hereunder, you shall provide for payment of the purchase price of the Shares being purchased through one or a combination of the following methods:

(a)

Cash (including check, bank draft or money order);



(b)

To the extent permitted by law, through a broker-assisted cashless exercise in which you irrevocably instruct a broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the purchase price of such Shares;



(c)

By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares (or in lieu of such delivery, by tender through attestation of such Shares in accordance with such procedures as the Committee may permit); or



(d)

By authorizing the Company to retain from the total number of Shares as to which the Option is exercised that number of Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares.

Notwithstanding the foregoing, you shall not be permitted to pay any portion of the purchase price with Shares if the Committee, in its sole discretion, determines that payment in such manner is undesirable.

Delivery of Shares. As soon as practicable after the Company receives the notice of exercise and payment provided for above, it shall deliver to the person exercising the Option, in the name of such person, a certificate or certificates representing the Shares being purchased (net of the number of Shares sold or withheld, if any, to pay the exercise price). The Company may alternatively satisfy this obligation to deliver Shares by a book entry made in the records of the Company's transfer agent or by electronically transferring such Shares to an account designated by the person exercising the Option. The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith. All Shares so issued shall be fully paid and nonassessable. Notwithstanding anything to the contrary in this Agreement, the Company shall not be required to issue or deliver any Shares

2

unless issuance and delivery complies with all applicable legal requirements, including compliance with applicable state and federal securities laws.

7.

Employment Requirement. This Option may be exercised only while you remain employed with the Company or a parent or subsidiary thereof, and only if you have been continuously so employed since the date of this Agreement; provided that:

(a)

This Option may be exercised for a period of one year after the date your employment ends if your employment ends because of death or Disability, but only to the extent it was exercisable immediately prior to the end of your employment.

(b)

If your employment terminates after a declaration made pursuant to Section 8 of this Agreement and Section 18 of the Plan in connection with a Fundamental Change, this Option may be exercised at any time during the period permitted by such declaration.

(c)

If your employment is terminated by the Company for Cause, this Option shall expire, and all rights to purchase Shares hereunder shall terminate immediately upon such termination.

(d)

If your employment terminates for any reason other than as provided above, this Option may be exercised at any time within three months after the time of such termination of employment, but only to the extent that it was exercisable immediately prior to such termination of employment.

Notwithstanding any provision of this Agreement, this Option may not be exercised after it has expired as provided in Section 5 of this Agreement.

8.

Acceleration of Option. If a Fundamental Change shall occur, then the Committee may, but shall not be obligated to, take the actions described in Section 18 of the Plan.

9.

Limitation on Transfer. During your lifetime, only you (or your Successor) may exercise the Option. You may not assign or transfer the Option except to a Successor in the event of your death.

10.

Market Standoff Agreement. If requested by the Company and an underwriter of Shares (or other securities) of the Company, you agree not to sell or otherwise transfer or dispose of any Shares (or other securities) of the Company held by you during the period requested by the managing underwriter following the effective date of a registration statement of the Company filed under the Securities Act of 1933, provided that all officers and directors of the Company are required to enter into similar agreements. Such agreement shall be in writing in a form satisfactory to the Company and such underwriter. The Company may impose stop-transfer instructions with respect to the Shares (or other securities) subject to the foregoing restriction until the end of such period.

11.

No Stockholder Rights Before Exercise. No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to this Option until the Share actually is issued to him/her upon exercise of this Option.

12.

Adjustments for Changes in Capitalization. This Option shall be subject to adjustments for changes in the Company's capitalization as provided in Section 17 of the Plan.

13.

Interpretation of This Agreement. All decisions and interpretations made by the Committee with regard to any question arising under this Agreement or the Plan shall be binding and conclusive upon the Company and you. This Agreement is subject to and shall be construed in accordance with the terms of the Plan. If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.

14.

Discontinuance of Employment. This Agreement shall not give you a right to continued employment with the Company or any Affiliate of the Company, and the Company or any such Affiliate

3

employing you may terminate your employment and otherwise deal with you without regard to the effect it may have upon you under this Agreement.

15.

Tax Withholding. Delivery of Shares upon exercise of this Option shall be subject to any required withholding taxes. As a condition precedent to receiving Shares upon exercise of this Option, you shall be required to pay to the Company, in accordance with the provisions of Section 15 of the Plan, an amount equal to the amount of any required tax withholdings.

16.

Option Subject to Plan, Certificate of Incorporation, and Bylaws. You acknowledge that this Option and the exercise thereof is subject to the Plan, the Certificate of Incorporation, as amended from time to time, and the Bylaws, as amended from time to time, of the Company, and any applicable federal or state laws, rules, or regulations.

17.

Obligation to Reserve Sufficient Shares. The Company shall at all times during the term of this Option reserve and keep available a sufficient number of Shares to satisfy this Agreement.

18.

Binding Effect. This Agreement shall be binding in all respects on your heirs, representatives, successors, and assigns.

19.

Choice of Law. This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).

[The remainder of this page is intentionally left blank.]

4

        IN WITNESS WHEREOF, you and the Company have executed this Agreement effective as of the    day of                        , 200  .

PARTICIPANT

[name]

CROCS, INC.

By:

Name:

Title:

QuickLinks

Exhibit 10.1

CROCS, INC. 2007 EQUITY INCENTIVE PLAN
Incentive Stock Option Agreement

EX-10.2

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 10.2

CROCS, INC.
2007 EQUITY INCENTIVE PLAN

Non-Statutory Stock Option Agreement

Name of Participant:
Number of Shares Covered:	Grant Date:
Exercise Price Per Share:	Expiration Date:
Exercise Schedule (Cumulative):

This is a Non-Statutory Stock Option Agreement ("Agreement") between Crocs, Inc., a Delaware corporation (the "Company"), and you, the Participant identified above, effective as of the Grant Date specified above.

Recitals*

        A.    The Company maintains the Crocs, Inc. 2007 Equity Incentive Plan (the "Plan"); and

        B.    Pursuant to the Plan, the Compensation Committee of the Board of Directors (the "Committee") administers the Plan, has the authority to determine the awards to be granted under the Plan and, subject to certain limitations contained in the Plan, has the authority to delegate such authority to persons who are not Non-Employee Directors of the Company; and

        C.    The Committee, either acting on its own or through certain of its authorized delegates, has determined that you are eligible to receive an award under the Plan in the form of a Non-Statutory Stock Option (the "Option");

        NOW, THEREFORE, the Company hereby grants this Option to you subject to the following terms and conditions:

Terms and Conditions

1.

Grant. You are granted this Option to purchase the number of Shares specified at the beginning of this Agreement.

2.

Exercise Price. The purchase price to you of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement, which price shall not be less than the Fair Market Value of a Share as of the Grant Date.

3.

Non-Statutory Stock Option. This Option is not intended to be an "incentive stock option" within the meaning of Section 422 of the Code.

4.

Exercise Schedule. This Option shall vest and become exercisable in accordance with the schedule specified at the beginning of this Agreement. The exercise schedule is cumulative, meaning that to the extent this Option has not been exercised and has not expired, terminated or been cancelled, it may be exercised with respect to any or all of the Shares as to which this Option has vested and become exercisable.

The vesting of this Option may be accelerated and it may be exercised in full under the circumstances described in Section 8 of this Agreement if it has not expired prior thereto.

*

Unless the context clearly indicates otherwise, any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future

5.

Expiration. This Option shall expire at 5:00 p.m. Mountain Time on the earliest of:

(a)

The Expiration Date specified at the beginning of this Agreement, which shall not be later than ten years after the Grant Date;

(b)

The last day of the period following the termination of your employment during which this Option can be exercised (as specified in Section 7 of this Agreement);

(c)

The date your employment is terminated through discharge for Cause; or

(d)

The date (if any) fixed for cancellation pursuant to Section 8 of this Agreement.

No one may exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.

6.

Procedure to Exercise Option.

Notice of Exercise. This Option may be exercised by delivering advance written notice of exercise to the Company at its headquarters in the form attached to this Agreement or in such other form as may be approved by the Company from time to time or by notifying the Company's outside Plan administrator of your intent to exercise and complying with all requirements set forth by such outside Plan administrator. If the person exercising this Option is not you, he/she also must submit appropriate proof of his/her right to exercise this Option.

Tender of Payment. Upon giving notice of any exercise hereunder, you shall provide for payment of the purchase price of the Shares being purchased and the amount of any tax withholding required in connection with such exercise as provided in Section 15 of the Plan through one or a combination of the following methods:

(a)

Cash (including check, bank draft or money order);



(b)

To the extent permitted by law, through a broker-assisted cashless exercise in which you irrevocably instruct a broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the purchase price of such Shares and the amount of any applicable withholding tax;



(c)

By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares and the amount of any applicable withholding tax (or in lieu of such delivery, by tender through attestation of such Shares in accordance with such procedures as the Committee may permit); or



(d)

By authorizing the Company to retain from the total number of Shares as to which the Option is exercised that number of Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares and the amount of any applicable withholding tax.

Notwithstanding the foregoing, you shall not be permitted to pay any portion of the purchase price with Shares if the Committee, in its sole discretion, determines that payment in such manner is undesirable.

Delivery of Shares. As soon as practicable after the Company receives the notice of exercise and payments provided for above, it shall deliver to the person exercising the Option, in the name of such person, a certificate or certificates representing the Shares being purchased (net of the number of Shares sold or withheld, if any, to pay the exercise price and withholding tax). The Company may alternatively satisfy this obligation to deliver Shares by a book entry made in the records of the Company's transfer agent or by electronically transferring such Shares to an account designated by the person exercising the Option. The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred

2

by it in connection therewith. All Shares so issued shall be fully paid and nonassessable. Notwithstanding anything to the contrary in this Agreement, the Company shall not be required to issue or deliver any Shares unless issuance and delivery complies with all applicable legal requirements, including compliance with applicable state and federal securities laws.

7.

Employment Requirement. This Option may be exercised only while you remain employed with the Company or an Affiliate thereof, and only if you have been continuously so employed since the date of this Agreement; provided that:

(a)

This Option may be exercised for a period of one year after the date your employment ends if your employment ends because of death, Disability or Retirement, but only to the extent it was exercisable immediately prior to the end of your employment.

(b)

If your employment terminates after a declaration made pursuant to Section 8 of this Agreement and Section 18 of the Plan in connection with a Fundamental Change, this Option may be exercised at any time during the period permitted by such declaration.

(c)

If your employment is terminated by the Company for Cause, this Option shall expire, and all rights to purchase Shares hereunder shall terminate immediately upon such termination.

(d)

If your employment terminates for any reason other than as provided above, this Option may be exercised at any time within three months after the time of such termination of employment, but only to the extent that it was exercisable immediately prior to such termination of employment.

Notwithstanding any provision of this Agreement, this Option may not be exercised after it has expired as provided in Section 5 of this Agreement.

8.

Acceleration of Option. If a Fundamental Change shall occur, then the Committee may, but shall not be obligated to, take the actions described in Section 18 of the Plan.

9.

Limitation on Transfer. This Option may be assigned or transferred only as permitted by and in accordance with Section 6(c) of the Plan, including the transfer of this Option to a Transferee so long as you do not receive any consideration for the transfer.

10.

Market Standoff Agreement. If requested by the Company and an underwriter of Shares (or other securities) of the Company, you agree not to sell or otherwise transfer or dispose of any Shares (or other securities) of the Company held by you during the period requested by the managing underwriter following the effective date of a registration statement of the Company filed under the Securities Act of 1933, provided that all officers and directors of the Company are required to enter into similar agreements. Such agreement shall be in writing in a form satisfactory to the Company and such underwriter. The Company may impose stop-transfer instructions with respect to the Shares (or other securities) subject to the foregoing restriction until the end of such period.

11.

No Stockholder Rights Before Exercise. No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to this Option until the Share actually is issued to him/her upon exercise of this Option.

12.

Adjustments for Changes in Capitalization. This Option shall be subject to adjustments for changes in the Company's capitalization as provided in Section 17 of the Plan.

13.

Interpretation of This Agreement. All decisions and interpretations made by the Committee with regard to any question arising under this Agreement or the Plan shall be binding and conclusive upon the Company and you. This Agreement is subject to and shall be construed in accordance with the terms of the Plan. If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.

3

14.

Discontinuance of Employment. This Agreement shall not give you a right to continued employment with the Company or any Affiliate of the Company, and the Company or any such Affiliate employing you may terminate your employment and otherwise deal with you without regard to the effect it may have upon you under this Agreement.

15.

Tax Withholding. Delivery of Shares upon exercise of this Option shall be subject to any required withholding taxes. As a condition precedent to receiving Shares upon exercise of this Option, you shall be required to pay to the Company, in accordance with the provisions of Section 15 of the Plan and Section 6 of this Agreement, an amount equal to the amount of any required tax withholdings.

16.

Option Subject to Plan, Certificate of Incorporation, and Bylaws. You acknowledge that this Option and the exercise thereof is subject to the Plan, the Articles of Incorporation, as amended from time to time, and the Bylaws, as amended from time to time, of the Company, and any applicable federal or state laws, rules, or regulations.

17.

Obligation to Reserve Sufficient Shares. The Company shall at all times during the term of this Option reserve and keep available a sufficient number of Shares to satisfy this Agreement.

18.

Binding Effect. This Agreement shall be binding in all respects on your heirs, representatives, successors, and assigns.

19.

Choice of Law. This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).

4

        IN WITNESS WHEREOF, you and the Company have executed this Agreement effective as of the    day of                        , 200  .

PARTICIPANT

[name]

CROCS, INC.

By:

Name:

Title:

QuickLinks

Exhibit 10.2

CROCS, INC. 2007 EQUITY INCENTIVE PLAN
Non-Statutory Stock Option Agreement

EX-10.3

QuickLinks -- Click here to rapidly navigate through this document

Exhibit 10.3

CROCS, INC.
2007 EQUITY INCENTIVE PLAN

Non-Statutory Stock Option Agreement (Non-Employee Director)

Name of Participant:
Number of Shares Covered:	Grant Date:
Exercise Price Per Share:	Expiration Date:
Exercise Schedule (Cumulative):

This is a Non-Statutory Stock Option Agreement ("Agreement") between Crocs, Inc., a Delaware corporation (the "Company"), and you, the Participant identified above, effective as of the Grant Date specified above.

Recitals*

        A.    The Company maintains the Crocs, Inc. 2007 Equity Incentive Plan (the "Plan"); and

        B.    Pursuant to the Plan, the Board of Directors (the "Board") has the authority to grant awards to Non-Employee Directors on terms and conditions to be determined by the Board.

        NOW, THEREFORE, the Company hereby grants option awards in the form of a Non-Statutory Stock Option (the "Option") to you subject to the following terms and conditions set by the Board:

Terms and Conditions

1.

Grant. You are granted this Option to purchase the number of Shares specified at the beginning of this Agreement.

2.

Exercise Price. The purchase price to you of each Share subject to this Option shall be the exercise price specified at the beginning of this Agreement, which price shall not be less than the Fair Market Value of a Share as of the Grant Date.

3.

Non-Statutory Stock Option. This Option is not intended to be an "incentive stock option" within the meaning of Section 422 of the Code.

4.

Exercise Schedule. This Option shall vest and become exercisable in accordance with the schedule specified at the beginning of this Agreement. The exercise schedule is cumulative, meaning that to the extent this Option has not been exercised and has not expired, terminated or been cancelled, it may be exercised with respect to any or all of the Shares as to which this Option has vested and become exercisable.

The vesting of this Option may be accelerated and it may be exercised in full under the circumstances described in Section 8 of this Agreement if it has not expired prior thereto.

5.

Expiration. This Option shall expire at 5:00 p.m. Mountain Time on the earliest of:

(a)

The Expiration Date specified at the beginning of this Agreement, which shall not be later than ten years after the Grant Date;

*

Unless the context clearly indicates otherwise, any capitalized term that is not defined in this Agreement shall have the meaning set forth in the Plan as it currently exists or as it is amended in the future

(b)

The last day of the period following the termination of your relationship with the Company as a Non-Employee Director or consultant (your "Relationship") during which this Option can be exercised (as specified in Section 7 of this Agreement);



(c)

The date your Relationship is terminated through discharge for Cause; or



(d)

The date (if any) fixed for cancellation pursuant to Section 8 of this Agreement.

No one may exercise this Option, in whole or in part, after it has expired, notwithstanding any other provision of this Agreement.

6.

Procedure to Exercise Option.

Notice of Exercise. This Option may be exercised by delivering advance written notice of exercise to the Company at its headquarters in the form attached to this Agreement or in such other form as may be approved by the Company from time to time or by notifying the Company's outside Plan administrator of your intent to exercise and complying with all requirements set forth by such outside Plan administrator. If the person exercising this Option is not you, he/she also must submit appropriate proof of his/her right to exercise this Option.

Tender of Payment. Upon giving notice of any exercise hereunder, you shall provide for payment of the purchase price of the Shares being purchased and the amount of any tax withholding required in connection with such exercise as provided in Section 15 of the Plan through one or a combination of the following methods:

(a)

Cash (including check, bank draft or money order);



(b)

To the extent permitted by law, through a broker-assisted cashless exercise in which you irrevocably instruct a broker to deliver proceeds of a sale of all or a portion of the Shares to be issued pursuant to the exercise to the Company in payment of the purchase price of such Shares and the amount of any applicable withholding tax;



(c)

By delivery to the Company of unencumbered Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares and the amount of any applicable withholding tax (or in lieu of such delivery, by tender through attestation of such Shares in accordance with such procedures as the Board may permit); or



(d)

By authorizing the Company to retain from the total number of Shares as to which the Option is exercised that number of Shares having an aggregate Fair Market Value on the date of exercise equal to the purchase price of such Shares and the amount of any applicable withholding tax.

Notwithstanding the foregoing, you shall not be permitted to pay any portion of the purchase price with Shares if the Board, in its sole discretion, determines that payment in such manner is undesirable.

Delivery of Shares. As soon as practicable after the Company receives the notice of exercise and payments provided for above, it shall deliver to the person exercising the Option, in the name of such person, a certificate or certificates representing the Shares being purchased (net of the number of Shares sold or withheld, if any, to pay the exercise price and withholding tax). The Company may alternatively satisfy this obligation to deliver Shares by a book entry made in the records of the Company's transfer agent or by electronically transferring such Shares to an account designated by the person exercising the Option. The Company shall pay any original issue or transfer taxes with respect to the issue or transfer of the Shares and all fees and expenses incurred by it in connection therewith. All Shares so issued shall be fully paid and nonassessable. Notwithstanding anything to the contrary in this Agreement, the Company shall not be required to

2

issue or deliver any Shares unless issuance and delivery complies with all applicable legal requirements, including compliance with applicable state and federal securities laws.

7.

Termination of Relationship with the Company.

(a)

This Option may be exercised for a period of one year after the date your Relationship ends if your Relationship ends because of death, Disability or Retirement, but only to the extent it was exercisable immediately prior to the end of your Relationship.

(b)

If your Relationship terminates after a declaration made pursuant to Section 8 of this Agreement and Section 18 of the Plan in connection with a Fundamental Change, this Option may be exercised at any time during the period permitted by such declaration.

(c)

If your Relationship is terminated by the Company for Cause, this Option shall expire, and all rights to purchase Shares hereunder shall terminate immediately upon such termination.

(d)

If your Relationship terminates for any reason other than as provided above, this Option may be exercised at any time within three months after the time of such termination of your Relationship, but only to the extent that it was exercisable immediately prior to such termination of your Relationship.

Notwithstanding any provision of this Agreement, this Option may not be exercised after it has expired as provided in Section 5 of this Agreement.

8.

Acceleration of Option. If a Fundamental Change shall occur, then the Board may, but shall not be obligated to, take the actions described in Section 18 of the Plan.

9.

Limitation on Transfer. This Option may be assigned or transferred only as permitted by and in accordance with Section 6(c) of the Plan, including the transfer of this Option to a Transferee so long as you do not receive any consideration for the transfer.

10.

Market Standoff Agreement. If requested by the Company and an underwriter of Shares (or other securities) of the Company, you agree not to sell or otherwise transfer or dispose of any Shares (or other securities) of the Company held by you during the period requested by the managing underwriter following the effective date of a registration statement of the Company filed under the Securities Act of 1933, provided that all officers and directors of the Company are required to enter into similar agreements. Such agreement shall be in writing in a form satisfactory to the Company and such underwriter. The Company may impose stop-transfer instructions with respect to the Shares (or other securities) subject to the foregoing restriction until the end of such period.

11.

No Stockholder Rights Before Exercise. No person shall have any of the rights of a stockholder of the Company with respect to any Share subject to this Option until the Share actually is issued to him/her upon exercise of this Option.

12.

Adjustments for Changes in Capitalization. This Option shall be subject to adjustments for changes in the Company's capitalization as provided in Section 17 of the Plan.

13.

Interpretation of This Agreement. All decisions and interpretations made by the Board with regard to any question arising under this Agreement or the Plan shall be binding and conclusive upon the Company and you. This Agreement is subject to and shall be construed in accordance with the terms of the Plan. If there is any inconsistency between the provisions of this Agreement and the Plan, the provisions of the Plan shall govern.

14.

Discontinuance of Relationship. This Agreement shall not give you a right to continued service as a Non-Employee Director or as a consultant to the Company, and the Board or the stockholders of the Company have the right, as the case may be, to remove or fail to re-elect you as a

3

Non-Employee Director or terminate your consulting relationship and otherwise deal with you without regard to the effect it may have upon you under this Agreement.

15.

Tax Withholding. Delivery of Shares upon exercise of this Option shall be subject to any required withholding taxes. As a condition precedent to receiving Shares upon exercise of this Option, you shall be required to pay to the Company, in accordance with the provisions of Section 15 of the Plan and Section 6 of this Agreement, an amount equal to the amount of any required tax withholdings.

16.

Option Subject to Plan, Certificate of Incorporation, and Bylaws. You acknowledge that this Option and the exercise thereof is subject to the Plan, the Articles of Incorporation, as amended from time to time, and the Bylaws, as amended from time to time, of the Company, and any applicable federal or state laws, rules, or regulations.

17.

Obligation to Reserve Sufficient Shares. The Company shall at all times during the term of this Option reserve and keep available a sufficient number of Shares to satisfy this Agreement.

18.

Binding Effect. This Agreement shall be binding in all respects on your heirs, representatives, successors, and assigns.

19.

Choice of Law. This Agreement is entered into under the laws of the State of Delaware and shall be construed and interpreted thereunder (without regard to its conflict of law principles).

4

        IN WITNESS WHEREOF, you and the Company have executed this Agreement effective as of the    day of                        , 200  .

PARTICIPANT

[name]

CROCS, INC.

By:

Name:

Title:

QuickLinks

Exhibit 10.3

CROCS, INC. 2007 EQUITY INCENTIVE PLAN
Non-Statutory Stock Option Agreement (Non-Employee Director)
Recitals

EX-31.1

QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 31.1

SECTION 302 CERTIFICATION

I, Ronald R. Snyder, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Crocs, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors or (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2007 /s/  RONALD R. SNYDER Ronald R. Snyder
President and Chief Executive Officer
(Principal Executive Officer)

QuickLinks

EXHIBIT 31.1

SECTION 302 CERTIFICATION

EX-31.2

QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 31.2

SECTION 302 CERTIFICATION

I, Peter S. Case, certify that:

1.

I have reviewed this quarterly report on Form 10-Q of Crocs, Inc.;

2.

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.

The registrant's other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Evaluated the effectiveness of the registrant's disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(c)

Disclosed in this report any change in the registrant's internal control over financial reporting that occurred during the registrant's most recent fiscal quarter (the registrant's fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant's internal control over financial reporting; and

5.

The registrant's other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant's auditors and the audit committee of the registrant's board of directors or (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant's ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant's internal control over financial reporting.

Date: November 14, 2007 /s/  PETER S. CASE Peter S. Case
Chief Financial Officer, Senior Vice President—Finance and Treasurer
(Principal Financial and Accounting Officer)

QuickLinks

EXHIBIT 31.2

SECTION 302 CERTIFICATION

EX-32.1

QuickLinks -- Click here to rapidly navigate through this document

EXHIBIT 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO SECTION 906
OF THE SARBANES-OXLEY ACT OF 2002

        The undersigned, Chief Executive Officer and Chief Financial Officer of Crocs, Inc., (the "Company") hereby certify, pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

(1)

The Quarterly Report on Form 10-Q of the Company for the three and nine months ended September 30, 2007 ("Form 10-Q") fully complies with the requirements of Section 13(a) of the Securities Exchange Act of 1934 (15 U.S.C. 78m); and

(2)

The information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company for the period covered by this report.

Date: Date: November 14, 2007	/s/  RONALD R. SNYDER Ronald R. Snyder President and Chief Executive Officer (Principal Executive Officer)
	/s/  PETER S. CASE Peter S. Case Chief Financial Officer, Senior Vice President—Finance and Treasurer (Principal Financial and Accounting Officer)

        A signed original of this written statement required by Section 906 has been provided to Crocs, Inc. and will be retained by Crocs, Inc. and furnished to the Securities and Exchange Commission or its staff on request.

QuickLinks

EXHIBIT 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002